Mesenchymal stem cells in kidney repair

Methods in Molecular Biology

Volumn 1416, Issue , 2016, Pages 89-107

  Morigi, Marina ^a   Rota, Cinzia ^a   Remuzzi, Giuseppe ^a,b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b PAPA GIOVANNI XXIII HOSPITAL   (Italy)

Author keywords

AKI; CKD; Glomeruli; Growth factors; Kidney; MSCs; Paracrine effect; Tissue regeneration; Tubules

Indexed keywords

CYTOKINE; GROWTH FACTOR;

ACUTE KIDNEY FAILURE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL COMMUNICATION; CELL FUNCTION; CHRONIC KIDNEY DISEASE; CYTOKINE RELEASE; EXOSOME; HUMAN; IMMUNOMODULATION; KIDNEY CELL; MEMBRANE MICROPARTICLE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); TISSUE REGENERATION; CELL DIFFERENTIATION; CYTOLOGY; MESENCHYMAL STROMA CELL; PROCEDURES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

ACUTE KIDNEY INJURY; CELL DIFFERENTIATION; CLINICAL TRIALS, PHASE I AS TOPIC; GUIDED TISSUE REGENERATION; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84990245718     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-3584-0_5     Document Type: Chapter

References (88)

1. Taylor PL, Barker RA, Blume KG et al (2010) Patients beware: commercialized stem cell treatments on the web. Cell Stem Cell 7:43-49
2. Daley GQ (2012) The promise and perils of stem cell therapeutics. Cell Stem Cell 10:740-749
3. Ranganath SH, Levy O, Inamdar MS et al (2012) Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell 10:244-258
4. Rosenzweig A (2006) Cardiac cell therapymixed results from mixed cells. N Engl J Med 355:1274-1277
5. Nowbar AN, Mielewczik M, Karavassilis M et al (2014) Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta-analysis. BMJ 348:g2688
6. Weissman I (2012) Stem cell therapies could change medicine… if they get the chance. Cell Stem Cell 10:663-665
7. Poulsom R, Forbes SJ, Hodivala-Dilke K et al (2001) Bone marrow contributes to renal parenchymal turnover and regeneration. J Pathol 195:229-235
8. Ito T, Suzuki A, Imai E et al (2001) Bone marrow is a reservoir of repopulating mesangial cells during glomerular remodeling. J Am Soc Nephrol 12:2625-2635
9. Li B, Morioka T, Uchiyama M et al (2006) Bone marrow cell infusion ameliorates progressive glomerulosclerosis in an experimental rat model. Kidney Int 69:323-330
10. Friedenstein AJ, Chailakhjan RK, Lalykina KS (1970) The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3:393-403
11. Dominici M, Le Blanc K, Mueller I et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317
12. Bianco P, Robey PG, Simmons PJ (2008) Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2:313-319
13. Bianco P, Cao X, Frenette PS et al (2013) The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat Med 19:35-42
14. Uccelli A, Moretta L, Pistoia V (2008) Mesenchymal stem cells in health and disease. Nat Rev Immunol 8:726-736
15. Edwards RG, Hollands P (2007) Will stem cells in cord blood, amniotic fluid, bone marrow and peripheral blood soon be unnecessary in transplantation? Reprod Biomed Online 14:396-401
16. Panepucci RA, SiufiJL, Silva WA Jr et al (2004) Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells. Stem Cells 22:1263-1278
17. Crisan M, Yap S, Casteilla L et al (2008) A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3:301-313
18. Caplan AI, Correa D (2011) The MSC: an injury drugstore. Cell Stem Cell 9:11-15
19. Teixeira FG, Carvalho MM, Sousa N et al (2013) Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration? Cell Mol Life Sci 70:3871-3882
20. Wagner J, Kean T, Young R et al (2009) Optimizing mesenchymal stem cell-based therapeutics. Curr Opin Biotechnol 20:531-536
21. Kupcova Skalnikova H (2013) Proteomic techniques for characterisation of mesenchymal stem cell secretome. Biochimie 95:2196-2211
22. Drago D, Cossetti C, Iraci N et al (2013) The stem cell secretome and its role in brain repair. Biochimie 95:2271-2285
23. Bronckaers A, Hilkens P, Martens W et al (2014) Mesenchymal stem/stromal cells as a pharmacological and therapeutic approach to accelerate angiogenesis. Pharmacol Ther 143:181-196
24. Abumaree M, Al Jumah M, Pace RA et al (2012) Immunosuppressive properties of mesenchymal stem cells. Stem Cell Rev 8:375-392
25. Bartholomew A, Sturgeon C, Siatskas M et al (2002) Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30:42-48
26. Di Nicola M, Carlo-Stella C, Magni M et al (2002) Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99:3838-3843
27. Casiraghi F, Remuzzi G, Perico N (2014) Mesenchymal stromal cells to promote kidney transplantation tolerance. Curr Opin Organ Transplant 19:47-53
28. English K (2013) Mechanisms of mesenchymal stromal cell immunomodulation. Immunol Cell Biol 91:19-26
29. Kim J, Hematti P (2009) Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. Exp Hematol 37:1445-1453
30. Baglio SR, Pegtel DM, Baldini N (2012) Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy. Front Physiol 3:359
31. Tomasoni S, Longaretti L, Rota C et al (2013) Transfer of growth factor receptor mRNA via exosomes unravels the regenerative effect of mesenchymal stem cells. Stem Cells Dev 22:772-780
32. Ratajczak J, Wysoczynski M, Hayek F et al (2006) Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 20:1487-1495
33. Camussi G, Deregibus MC, Bruno S et al (2010) Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int 78:838-848
34. Devarajan P (2006) Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 17:1503-1520
35. Coca SG, Yusuf B, Shlipak MG et al (2009) Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 53:961-973
36. Star RA (1998) Treatment of acute renal failure. Kidney Int 54:1817-1831
37. Grino JM (1994) BN 52021: a platelet activating factor antagonist for preventing post-transplant renal failure. A double-blind, randomized study. The BN 52021 Study Group in Renal Transplantation. Ann Intern Med 121:345-347
38. Haug CE, Colvin RB, Delmonico FLet al (1993) A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. Transplantation 55:766-772
39. Bonventre JV (2003) Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure. J Am Soc Nephrol 14(Suppl 1):S55-S61
40. Lameire N, Van Biesen W, Vanholder R (2008) Acute kidney injury. Lancet 372:1863-1865
41. Benigni A, Morigi M, Remuzzi G (2010) Kidney regeneration. Lancet 375:1310-1317
42. Aejaz HM, Aleem AK, Parveen N et al (2007) Stem cell therapy-present status. Transplant Proc 39:694-699
43. Daley GQ, Scadden DT (2008) Prospects for stem cell-based therapy. Cell 132:544-548
44. Lindvall O, Kokaia Z (2006) Stem cells for the treatment of neurological disorders. Nature 441:1094-1096
45. Laflamme MA, Murry CE (2005) Regenerating the heart. Nat Biotechnol 23:845-856
46. Little MH (2006) Regrow or repair: potential regenerative therapies for the kidney. J Am Soc Nephrol 17:2390-2401
47. Cantley LG (2005) Adult stem cells in the repair of the injured renal tubule. Nat Clin Pract Nephrol 1:22-32
48. Morigi M, Benigni A, Remuzzi G et al (2006) The regenerative potential of stem cells in acute renal failure. Cell Transplant 15(Suppl 1):S111-S117
49. Morigi M, Imberti B, Zoja C et al (2004) Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol 15:1794-1804
50. Herrera MB, Bussolati B, Bruno S et al (2004) Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int J Mol Med 14:1035-1041
51. Togel F, Hu Z, Weiss K et al (2005) Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 289:F31-F42
52. Morigi M, Introna M, Imberti B et al (2008) Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice. Stem Cells 26:2075-2082
53. Morigi M, Rota C, Montemurro T et al (2010) Life-sparing effect of human cord bloodmesenchymal stem cells in experimental acute kidney injury. Stem Cells 28:513-522
54. Rota C, Imberti B, Pozzobon M et al (2012) Human amniotic fluid stem cell preconditioning improves their regenerative potential. Stem Cells Dev 21:1911-1923
55. Kim JH, Park DJ, Yun JC et al (2012) Human adipose tissue-derived mesenchymal stem cells protect kidneys from cisplatin nephrotoxicity in rats. Am J Physiol Renal Physiol 302:F1141-F1150
56. Katsuno T, Ozaki T, Saka Y et al (2013) Low serum cultured adipose tissue-derived stromal cells ameliorate acute kidney injury in rats. Cell Transplant 22:287-297
57. Flynn A, Barry F, O'Brien T (2007) UC bloodderived mesenchymal stromal cells: an overview. Cytotherapy 9:717-726
58. Sanchez-Ramos J (2006) Stem cells from umbilical cord blood. Semin Reprod Med 24:358-369
59. Erices A, Conget P, Minguell JJ (2000) Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 109:235-242
60. Lee OK, Kuo TK, Chen WM et al (2004) Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 103:1669-1675
61. Seres KB, Hollands P (2010) Cord blood: the future of regenerative medicine? Reprod Biomed Online 20:98-102
62. Du T, Cheng J, Zhong L et al (2012) The alleviation of acute and chronic kidney injury by human Wharton’s jelly-derived mesenchymal stromal cells triggered by ischemia-reperfusion injury via an endocrine mechanism. Cytotherapy 14:1215-1227
63. Fang TC, Pang CY, Chiu SC et al (2012) Renoprotective effect of human umbilical cord-derived mesenchymal stem cells in immunodeficient mice suffering from acute kidney injury. PLoS One 7, e46504
64. De Coppi P, Bartsch G Jr, Siddiqui MM et al (2007) Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25:100-106
65. Gupta S, Verfaillie C, Chmielewski D et al (2002) A role for extrarenal cells in the regeneration following acute renal failure. Kidney Int 62:1285-1290
66. Bi B, Schmitt R, Israilova M et al (2007) Stromal cells protect against acute tubular injury via an endocrine effect. J Am Soc Nephrol 18:2486-2496
67. Togel F, Weiss K, Yang Y et al (2007) Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol 292:F1626-F1635
68. Hirschberg R, Ding H (1998) Mechanisms of insulin-like growth factor-I-induced accelerated recovery in experimental ischemic acute renal failure. Miner Electrolyte Metab 24:211-219
69. Imberti B, Morigi M, Tomasoni S et al (2007) Insulin-like growth factor-1 sustains stem cell mediated renal repair. J Am Soc Nephrol 18:2921-2928
70. Togel F, Zhang P, Hu Z et al (2009) VEGF is a mediator of the renoprotective effects of multipotent marrow stromal cells in acute kidney injury. J Cell Mol Med 13:2109-2114
71. Hagiwara M, Shen B, Chao L et al (2008) Kallikrein-modified mesenchymal stem cell implantation provides enhanced protection against acute ischemic kidney injury by inhibiting apoptosis and inflammation. Hum Gene Ther 19:807-819
72. Mias C, Trouche E, Seguelas MH et al (2008) Ex vivo pretreatment with melatonin improves survival, proangiogenic/mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidney. Stem Cells 26:1749-1757
73. Xinaris C, Morigi M, Benedetti V et al (2013) A novel strategy to enhance mesenchymal stem cell migration capacity and promote tissue repair in an injury specific fashion. Cell Transplant 22:423-436
74. Bruno S, Grange C, Deregibus MC et al (2009) Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 20:1053-1067
75. Collino F, Deregibus MC, Bruno S et al (2010) Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS One 5, e11803
76. Lindoso RS, Collino F, Bruno S et al (2014) Extracellular vesicles released from mesenchymal stromal cells modulate miRNA in renal tubular cells and inhibit ATP depletion injury. Stem Cells Dev 23(15):1809-1819
77. Kunter U, Rong S, Moeller MJ et al (2011) Mesenchymal stem cells as a therapeutic approach to glomerular diseases: benefits and risks. Kidney Int Suppl 1:68-73
78. Ninichuk V, Gross O, Segerer S et al (2006) Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice. Kidney Int 70:121-129
79. Guillot PV, Cook HT, Pusey CD et al (2008) Transplantation of human fetal mesenchymal stem cells improves glomerulopathy in a collagen type I alpha 2-deficient mouse. J Pathol 214:627-636
80. Choi S, Park M, Kim J et al (2009) The role of mesenchymal stem cells in the functional improvement of chronic renal failure. Stem Cells Dev 18:521-529
81. Cavaglieri RC, Martini D, Sogayar MC et al (2009) Mesenchymal stem cells delivered at the subcapsule of the kidney ameliorate renal disease in the rat remnant kidney model. Transplant Proc 41:947-951
82. Semedo P, Correa-Costa M, Antonio Cenedeze M et al (2009) Mesenchymal stem cells attenuate renal fibrosis through immune modulation and remodeling properties in a rat remnant kidney model. Stem Cells 27:3063-3073
83. Kunter U, Rong S, Djuric Z et al (2006) Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. J Am Soc Nephrol 17: 2202-2212
84. Kunter U, Rong S, Boor P et al (2007) Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. J Am Soc Nephrol 18:1754-1764
85. Sun L, Akiyama K, Zhang H et al (2009) Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. Stem Cells 27:1421-1432
86. Zoja C, Garcia PB, Rota C et al (2012) Mesenchymal stem cell therapy promotes renal repair by limiting glomerular podocyte and progenitor cell dysfunction in adriamycininduced nephropathy. Am J Physiol Renal Physiol 303:F1370-F1381
87. Gooch A, Doty J, Flores J et al (2008) Initial report on a phase I clinical trial: prevention and treatment of post-operative acute kidney injury with allogeneic mesenchymal stem cell in patients who require on-pump cardiac surgery. Cell Ther Transplant [Online] 1:31-35
88. Togel FE, Westenfelder C (2010) Mesenchymal stem cells: a new therapeutic tool for AKI. Nat Rev Nephrol 6:179-183